BIO CEO & Investor Conference

Feb 10-11, 2020・New York, New York
Accelerate Discovery. Amplify Returns.

Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts, and senior biotechnology executives, in one location.

Partner with Top Investors

Over 340 investors have already registered, including ARCH Venture Partners, New Enterprise Associates, Sofinnova Ventures, and SR One, who are currently active in the partnering system and read to meet! Partnering activity is breaking records, with total meeting requests up 36% and accepted requests pacing 23% ahead of 2019.

Hanshake
CEO_Web-Ebrochure
Last Chance to Register! View the Latest Program

This year’s event will attract the industry’s who’s who of business thought leaders, clinical innovators and financial market experts. In addition to networking, company presentations and partnering meeting, session topics will cover advances in gene, liver, and cardiovascular disease therapies, developing an inclusive workforce and the global economy (policy and market outlook).

Featured Registration Packages
Company Presentation + Partnering
Starting at: $1,650  

What's Included: 

  • BIO One-on-One Partnering
  • 13-minute presentation to showcase your pipeline
  • Full programming: Panels and Fireside Chats
  • Welcome reception
  • Conference meals and coffee service
Partnering Registration
Starting at: $1,000  

 

What's Included

  • BIO One-on-One Partnering
  • Full programming: Panels and Fireside Chats
  • Welcome reception
  • Conference meals and coffee service
Last Chance to Apply to Present

Approximately 150 companies have been hand-selected to showcase their pipelines, licensing and investment goals, including Newron Pharmaceuticals, XyloCor Therapeutics, Anima Biotech, and Greenwich LifeSciences, plus our Buzz of BIO winners: Breakthrough Genomics, AZTherapies, and Brainstorm Cell Therapeutics. View them here.

BIO Executive Leadership Course

Applying Game Theory to Negotiations and Business Development: Spotlights on Deal Making and the Elevator Pitch

This half-day workshop is designed for executives who wish to implement the learnings from Game Theory to enhance their Elevator Pitch and Negotiations skills for pursuing business development deals and strategic decision making. 

See What Happened in 2019

Video still from CEO 2019

Top Blog Posts